Nina Reßing

Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor

Sanil Bhatia, Viktoria Krieger, M. Groll et al. · Journal of Medicinal Chemistry · 2018 · 77 citations · Full text

Medicine, Oncology, Pharmacology +13

Multicomponent Synthesis, Binding Mode, and Structure–Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups

Nina Reßing, Melf Sönnichsen, J.D. Osko et al. · Journal of Medicinal Chemistry · 2020 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b>

Beate König, P. R. Watson, Nina Reßing et al. · Journal of Medicinal Chemistry · 2023 · 47 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia

Nina Reßing, Julian Schliehe‐Diecks, P. R. Watson et al. · Journal of Medicinal Chemistry · 2022 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity

Nina Reßing, Viktoria Marquardt, Christoph G. W. Gertzen et al. · MedChemComm · 2018 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14